Cipla submits press release

22 Jul 2019 Evaluate

Cipla has informed about submission of press release dated 22nd July, 2019 regarding its wholly owned step down subsidiary lnvaGen Pharmaceuticals Inc. receives final approval for generic version of Pfizer's Lyrica (Pregabalin Capsules, 25mg, 50mg, 75mg, 100 mg, 150mg, 200mg, 225mg, 300mg). 

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1351.85 4.20 (0.31%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×